KVISTGAARD, Denmark, May 27, 2014 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company's share capital has been increased by nominally DKK 185,020 as a consequence of the exercise of warrants. After registration of the capital increase, Bavarian Nordic A/S' share capital amounts to DKK 261,128,630. The exercise price for the new shares is DKK 114 per share of nominal DKK 10. The gross proceeds to Bavarian Nordic A/S from the capital increase amounts to DKK 2,109,228.00. Each share of nominally DKK 10 carries one vote at general meetings in the company. The new shares give rights to dividend and other rights from the time of subscription. The new shares are issued without pre-emptions rights for the company's shareholders. The new shares are expected to be admitted to trading and official listing on NASDAQ OMX Copenhagen on May 28, 2014. The revised Articles of Association will be published separately and will subsequently be available on the Company's website. The content of this announcement does not affect the Company's expectations for the financial results for 2014. Anders Hedegaard, President & CEO. About Bavarian Nordic Bavarian Nordic is an international biotechnology company developing and manufacturing novel cancer immunotherapies and vaccines for infectious diseases. Lead product candidates are PROSTVAC(®), an immunotherapy product candidate for advanced prostate cancer that is the subject of an ongoing pivotal Phase 3 clinical trial, and IMVAMUNE(®), a non-replicating smallpox vaccine candidate in Phase 3 development, which is being developed and supplied for emergency use to the U.S. Strategic National Stockpile under a contract with the U.S. Government. The vaccine is approved in Canada under the trade name IMVAMUNE and in the European Union under the trade name IMVANEX(®). Bavarian Nordic's shares are listed on NASDAQ OMX Copenhagen under the symbol BAVA (Reuters: BAVA.CO, Bloomberg: BAVA.DC). The company has a sponsored Level 1 ADR program listed in the US (OTC) under the symbol BVNRY. For more information, visit www.bavarian-nordic.com. Contacts Rolf Sass Sørensen, Vice President Investor Relations (EU). Phone +45 61 77 47 43 Seth Lewis, Vice President Investor Relations (US). Phone + 1 978-298-5654 Forward-looking statements This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law. [HUG#1788675]
Bavarian Nordic A/S Issues New Shares in Connection with
Top 10 Most Recent News Articles
AI Use Hits 93% in Health Systems' Digital Shift
Healthcare's AI Surge: Jumping the Adoption Hurdle The digital health landscape isn't just humming along—it's hitting high gear. AI, once the shiny toy in innovation's toolkit, is now a fixture in 93.2% of healthcare systems according to CHIME's latest findings. For anyone keeping score, that's a hefty leap and paints a picture where AI isn't just in the game, it's...
Continue Reading
Dana Concludes Tender Offers for Senior Notes
An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...
Continue Reading
Later's NYC Summit Reinvents Social Commerce Game Plan
Creators and Corporates Collide Imagine this: an NYC stage not adorned with Broadway's finest, but with digital maestros steering a new age in social commerce. That's what Later is betting on with their Creator Live summit, debuting in the bustling heart of New York City. We're talking about influencers not just as Instagram stars, but as key players in a $480 billion...
Continue Reading
Koppers Faces SEC Scrutiny After Earnings Miss
Koppers' Third-Quarter Blues: Missing the Mark Koppers Holdings Inc. (NYSE: KOP) took a hard hit this quarter, missing Wall Street's earnings expectations by a mile. The adjusted earnings per share came in at just $0.77, while the suits down on Wall Street were expecting something closer to $1.34 to $1.37. Now, if you’re holding KOP in your portfolio, you're probably...
Continue Reading
National Police Assoc. Urges House to Pass PTSD Act
An Urgent Call for Action on PTSD Support Alright folks, this ain't your typical investment rundown, but it's got stakes just the same. The National Police Association is sounding the horn for the House to pass the Fighting Post-Traumatic Stress Disorder Act of 2025 (S. 825). Now, if you've been around the block, you know legislation can play out like a market...
Continue Reading
CR&R Workers Join Teamsters, Fight for Fair Conditions
Waste Workers Push Back Against Corporate Pressure The Southern California sun isn't the only thing heating up these days; the waste workers at CR&R Environmental Services have cranked up the heat by voting to join Teamsters Local 396. It's like Groundhog Day in the world of labor rights—same story, different locale, workers banding together for a fair shot. A Stand...
Continue Reading
SOCSA: The Future of Safety in Confined Spaces?
Autonomous Tech Meets Safety Regulations Some days innovation hits like a ton of bricks, and here we go again—this time with a gizmo aiming to shake up the safety game in confined spaces. Enter the SOCSA, the Self Operating Confined Space Attendant, designed by a seasoned agriculture worker who's had a ringside seat to enough OSHA rule breaches to fill a book. But ain't...
Continue Reading
Accuray Finishes Key Deal, Resetting Financial Trajectory
Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...
Continue Reading
Citigroup, Scotia Aid TSTT in $500M Note Offering
Kicking off with a banger that’s got financial water coolers buzzing, Greenberg Traurig just pulled a rabbit out of the hat helping Citigroup and Scotia Capital orchestrate a chunky near $500 million dual-currency notes deal for Telecommunications Services of Trinidad and Tobago Limited (TSTT). Now, this isn’t your run-of-the-mill market maneuver. We're seeing a...
Continue Reading
Agiloft Navigates New Growth Phase with Key Leadership
Leadership Shifts Steer Agiloft's EMEA Journey Agiloft's latest shake-ups in leadership signal a determined charge through EMEA's bustling markets. Nick Bowles, a seasoned veteran in enterprise software, steps into the limelight as Senior Vice President, while Jim Leason shifts gears into a customer-focused advisory role. These aren’t just routine hiring...
Continue ReadingTop 5 Most Recently Viewed Articles
Exploring Innovative Glaucoma Research with 2025 Grants Announcement
2025 Shaffer Grants Foster Groundbreaking Glaucoma Research In an exciting development in the field of ophthalmology, the Glaucoma Research Foundation (GRF) has revealed its nine recipients of the prestigious 2025 Shaffer Research Grants, totaling $55,000. These grants are designed to support innovative research aimed at understanding and potentially transforming...
Continue Reading
Beyond Air's Participation in Upcoming Investment Conference
Beyond Air to Engage at H.C. Wainwright Conference Beyond Air, Inc. (NASDAQ: XAIR), a pioneering biopharmaceutical company known for its innovative approach to medical devices, recently declared its commitment to participate in the H.C. Wainwright 27th Annual Global Investment Conference. Steve Lisi, the Chairman and Chief Executive Officer, will represent the company at...
Continue Reading
Investors Urged to Act on Sable Offshore Corp. Securities Case
Investors Now Have an Important Opportunity with Sable Offshore Corp. In light of recent developments, investor awareness regarding Sable Offshore Corp. (NYSE: SOC) has become crucial. Allegations of securities fraud have emerged, prompting a thorough investigation led by the DJS Law Group. This investigation centers around potential violations of securities laws, raising...
Continue Reading
Coeur Mining Prepares for Q4 and Full-Year 2024 Earnings Results
Coeur Mining Earnings Report Announcement Coeur Mining, Inc. (NYSE: CDE) is gearing up to release its operational and financial outcomes for the fourth quarter and the full year of 2024. This report is poised to be made public following the close of the New York Stock Exchange on a specified date. Following the announcement, Coeur will host a conference call to discuss...
Continue Reading
Exploring Option Care Health's Robust Financial Victory for 2024
Financial Overview of Option Care Health Option Care Health, Inc. (NASDAQ: OPCH), recognized as the largest independent provider of home and alternate site infusion services, recently shared its financial results for the fourth quarter and the entirety of 2024. Their performance reflects strategic execution and strong market demand despite a challenging environment....
Continue Reading